AWM
RKDA icon

Atticus Wealth Management’s Arcadia Biosciences RKDA Stock Holding History

Atticus Wealth Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-272
Closed -$1.17K – 530
2025
Q2 		$1.17K Hold
272
– – ﹤0.01% 593
2025
Q1 		$808 Hold
272
– – ﹤0.01% 469
2024
Q4 		$1.61K Buy
+272
New +$1.12K ﹤0.01% 477

Other funds holding RKDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Atticus Wealth Management's RKDA Position: Q3 2025 in Review

Atticus Wealth Management sold out of Arcadia Biosciences (RKDA) in Q3 2025, closing a stake of 272 shares — an estimated $1.17K sold.

Atticus Wealth Management first reported a position in RKDA in Q4 2024 and held it in 3 quarters. The position peaked at $1.61K in Q4 2024. 16 funds tracked by Wall St. Rank hold RKDA as of Q3 2025.

  • Atticus Wealth Management reported no remaining Arcadia Biosciences position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 272 Arcadia Biosciences shares in Q3 2025, an estimated $1.17K.
  • Atticus Wealth Management first reported a position in Arcadia Biosciences in Q4 2024 and held it in 3 quarters.
  • Atticus Wealth Management's Arcadia Biosciences position peaked at $1.61K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.